Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.
Successful treatment for neuromyelitis optica with systemic lupus erythematosus.
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Temporal aspects of visual perception in demyelinative diseases.
Cyclosporine in the treatment of a case of fulminant and refractory acute disseminated encephalomyelitis.
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation.
Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
Resolvin d1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses.
Role of STIM-dependent Ca(2+) Influx in Regulatory B Cells.
Autonomic dysfunction in multiple sclerosis.
Paracrine Effects of Mesenchymal Stem Cells-Conditioned Medium on Microglial Cytokines Expression and Nitric Oxide Production.
Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free.
Identification of Dominant Human Aquaporin 4 T-Cell Epitopes: Observations in Neuromyelitis Optica With Implications for Other Autoimmune DisordershAQP4 T-Cell Epitopes.
Fingolimod and multiple sclerosis: Four cautionary tales.
The Link between CD6 and Autoimmunity: Genetic and Cellular Associations.
[Consensus document on spasticity in patients with multiple sclerosis.]
A PheWAS approach in studying HLA-DRB1*1501.
Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D.
Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.
Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity.
Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation.
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.
Live-Imaging in the CNS: New Insights on Oligodendrocytes, Myelination, and their Responses to Inflammation.
Long-term efficacy of Gilenya® reinforced by new 'no evidence of disease activity' (NEDA-4) analysis in MS patients over seven years

Pages